Cynthia A. Challener Ph.D.

The Data Generation
Wednesday, March 15, 2017
The pharmaceutical market landscape remains tremendously dynamic in 2017. Outsourcing practices for drug discovery, product and process development, clinical trials and manufacturing continue to evolve as well. Data — ‘Big... read more
Industry Benchmark
Wednesday, March 15, 2017
At the heart of That’s Nice is the Nice Insight division, which provides data and analysis from proprietary annual surveys as well as custom primary and secondary research of many kinds. Nice Insight is tasked every year... read more
A Foundation of Innovation
Thursday, September 29, 2016
Innovation is at the heart of the pharmaceutical industry. Researchers develop innovative approaches to understanding biological processes, including the identification of potential new targets for which novel drug ... read more
Transforming The Pharmaceutical Industry Pipeline with In Silico Approaches
Thursday, September 29, 2016
Most of the revolutions that happened in silico,” says Douglas Krafte, Chief Scientific Officer of Icagen, Inc., “happened in the subfields such as biology and chemistry, not in the fully integrated design and ... read more
Future Pharma Partner Models – Regulation 3.0
Friday, July 29, 2016
At one point the future was more about the drug — finding the compounds and molecules that stopped the pain, killed the infection or immunized humans from history’s great diseases. read more
Future Pharma Partner Models - Effective Drug Delivery
Friday, July 29, 2016
The primary function of drug delivery is to facilitate active pharmaceutical ingredients reaching the target site and exerting a desired efficacy and safety profile. Drug makers have been relying heavily on drug delivery... read more
Future Pharma Partner Models - Outsourcing Trends in API Development & Manufacturing
Friday, July 29, 2016
As the population increases and the number of regional markets entering the global landscape continues to mount, drug companies are feeling pressure to bring drugs to market more quickly. CDMO outsourcing remains a key ... read more
Future Pharma Partner Models - Unique Delivery & Design
Friday, July 29, 2016
For optimal pharmacokinetics, sometimes it’s about getting the right amount of a drug to the right place at the right time. Whether a drug is delivered orally, parenterally or through some other method like inhalation, ... read more
Future Pharma Partner Models - Next-Generation Therapies
Friday, July 29, 2016
Many of the most promising next generation drug products are based on biologic active pharmaceutical ingredients that require new technologies that enable their manufacture, characterization (identity, viability, purity... read more
Collaboration Is the Name of the Game
Friday, July 29, 2016
The rapid changes occurring in the pharmaceutical industry are placing mounting pressures on (bio) pharmaceutical companies to accomplish more with less. Outsourcing to access unique technologies, lower costs and ... read more